tiprankstipranks
Trending News
More News >
Catalyst Pharma (CPRX)
NASDAQ:CPRX
US Market

Catalyst Pharma (CPRX) Technical Analysis

Compare
2,262 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Catalyst Pharma’s (CPRX) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Catalyst Pharma is a Sell.
Catalyst Pharma’s (CPRX) 20-Day exponential moving average is 22.87, while Catalyst Pharma’s (CPRX) share price is $23.45, making it a Buy.
Catalyst Pharma’s (CPRX) 50-Day exponential moving average is 22.73, while Catalyst Pharma’s (CPRX) share price is $23.45, making it a Buy.

Catalyst Pharma (CPRX) Pivot Points

Apr 28, 2025, 02:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
22.66
22.85
23.02
23.21
23.38
23.57
23.74
Fibonacci
22.85
22.99
23.07
23.21
23.35
23.43
23.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Catalyst Pharma (CPRX) Moving Averages

Apr 28, 2025, 02:19 AM
Period
Simple
Exponential
MA5
22.88Buy
23.04Buy
MA10
22.72Buy
22.88Buy
MA20
22.95Buy
22.87Buy
MA50
22.64Buy
22.73Buy
MA100
22.38Buy
22.23Buy
MA200
21.15Buy
20.70Buy
Catalyst Pharma’s (CPRX) 10-Day exponential moving average is 22.88, while Catalyst Pharma’s (CPRX) share price is $23.45, making it a Buy.
Catalyst Pharma’s (CPRX) 100-Day exponential moving average is 22.23, while Catalyst Pharma’s (CPRX) share price is $23.45, making it a Buy.
Catalyst Pharma’s (CPRX) stock price is $23.45 and Catalyst Pharma’s (CPRX) 50-day simple moving average is 22.64, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $23.45 and Catalyst Pharma’s (CPRX) 100-day simple moving average is 22.38, creating a Buy signal.
Catalyst Pharma’s (CPRX) stock price is $23.45 and Catalyst Pharma’s (CPRX) 200-day simple moving average is 21.15, creating a Buy signal.

Catalyst Pharma (CPRX) Technical Indicators

Apr 28, 2025, 02:19 AM
Name
Value
Implied Action
RSI (14)
54.03
Neutral
STOCH (9,6)
89.44
Sell
STOCHRSI (14)
80.04
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
16.23
Buy
Williams %R
-2.24
Sell
CCI (14)
31.07
Neutral
ATR (14)
1.03
-
Ultimate Oscillator
49.43
Neutral
ROC
1.65
Buy
Catalyst Pharma’s (CPRX) Relative Strength Index (RSI) is 54.03, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Trend Strength Indicator (ADX) is 16.23, creating a Buy signal.
Catalyst Pharma’s (CPRX) Commodity Channel Index (CCI) is 31.07, creating a Neutral signal.
Catalyst Pharma’s (CPRX) Price Rate of Change (ROC) is 1.65, creating a Buy signal.

FAQ

Is CPRX a Buy, Hold, or Sell?
Based on CPRX’s technical indicators, CPRX is a Buy.
    What is CPRX’s RSI (14)?
    CPRX’s RSI (14) is 54.03, which suggests CPRX is a Neutral.
      What is CPRX’s MACD?
      CPRX’s MACD is <0.01, which suggests CPRX is a Sell.
        What is CPRX’s 5-day moving average?
        CPRX’s 5-day moving average is 22.88, which suggests CPRX is a Buy.
          What is CPRX’s 20-day moving average?
          CPRX 20-day moving average is 22.95, which suggests CPRX is a Buy.
            What is CPRX’s 50-day moving average?
            CPRX’s 50-day moving average is 22.64, which suggests CPRX is a Buy.
              What is CPRX’s 200-day moving average?
              CPRX’s 200-day moving average is 21.15, which suggests CPRX is a Buy.
                What is CPRX’s Williams % R (14)?
                CPRX’s Williams % R (14) is -2.24, which suggests CPRX is a Sell.
                  What is CPRX’s CCI (14)?
                  CPRX’s CCI (14) is 31.07, which suggests CPRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis